Wells Fargo & Company »

Neubase Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $34 79 0.44
2023-12-31 $58 79 0.74
2023-09-30 $55 65 0.86
2023-06-30 $113 62 1.83

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth (UNH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Wells Fargo & Company

Top funds holding Neubase Therapeutics

DME Capital Management
Greenlight Capital
Point72 Asset Management
Carnegie Mellon University
Vanguard Group
Kestra Advisory Services
Springbok Capital Management
Geode Capital Management
UBS Group
Tower Research Capital
Cubist Systematic Strategies
Bank of America Corporation
First Manhattan
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Neubase Therapeutics